{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-096362","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.737447+00:00","generated_at":"2026-05-31T06:37:36.780478+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Entero Therapeutics subsidiary receives default suspension, but no waiver","bullets":["On August 29, 2024, ImmunogenX received letter from Lender Mattress Liquidators suspending MAE Default under Credit Agreement.","Original Notice of Default was received on August 2, 2024, alleging Material Adverse Effect and accelerating all obligations.","Lender's suspension is not a waiver; all rights regarding enforcement of MAE Default are expressly reserved.","No principal amount or financial impact disclosed in filing; discussions are ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-096362","json":"https://secwatch.observer/filing/0001104659-24-096362.json","markdown":"https://secwatch.observer/filing/0001104659-24-096362.md","text":"https://secwatch.observer/filing/0001104659-24-096362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924096362/0001104659-24-096362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924096362/tm2423257d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:37:36.780478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}